grant
Cancer Immunology Research Program
NIHUS FederalResearch GrantFY2025Animal ModelAnimal Models and Related StudiesAwardBiological MarkersCCSGCancer BiologyCancer Center Support GrantCancer PatientCancer TreatmentCancersCell TherapyCheckpoint inhibitorClinicClinicalClinical EvaluationClinical TestingClinical TrialsCollaborationsCommunicationDedicationsDevelopmentDevelopmental TherapeuticsDevelopmental Therapeutics ProgramDevelopmental TherapyDoctor of PhilosophyEvaluationFacultyFundingFutureGoalsImmuneImmune TargetingImmune checkpoint inhibitorImmune mediated therapyImmune responseImmunesImmunobiologyImmunologically Directed TherapyImmunologistImmunologyImmunooncologyImmunophysiologyImmunotherapyInfectionInflammationInfrastructureInnate Immune SystemInternationalInvestigatorsJournalsLeadLeadershipLinkMagazineMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMedicalMissionModelingNational Academy of SciencesPaperPatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPb elementPh.D.PhDPlayProcessPublicationsPublishingRegulationResearchResearch PersonnelResearch ResourcesResearchersResource SharingResourcesRoleScientific PublicationScientistStrategic PlanningTestingTrainingTranslatingTranslationsUnited States National Academy of SciencesWorkanti-canceranti-cancer immunotherapyanti-cancer therapyanti-tumor immune responseanticancer immunotherapyarmbio-markersbiologic markerbiomarkercancer immunologycancer immunotherapycancer therapycancer-directed therapycare outcomescell based interventioncell mediated interventioncell mediated therapiescell-based therapeuticcell-based therapycellular therapeuticcellular therapyclinical testdevelopmentalempowermentexperiencehealth care outcomesheavy metal Pbheavy metal leadhost responseimmune check point inhibitorimmune resistanceimmune system responseimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based cancer therapiesimmune-based therapiesimmune-based treatmentsimmune-oncologyimmune-resistantimmuno oncologyimmuno therapyimmunology oncologyimmunoresistanceimmunoresponseimmunotherapy for cancerimmunotherapy of cancerimprovedinsightmalignancymembermodel of animalmortalityneoplasm immunologyneoplasm/cancernew approachesnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapeuticsnew therapynew therapy approachesnew treatment approachnew treatment strategynext generationnext generation therapeuticsnovel approachesnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel strategiesnovel strategynovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapeuticsnovel therapynovel therapy approachoncoimmunologypatient oriented outcomesprogramsresearch clinical testingsocial roletranslationtranslation strategytranslational approachtranslational strategytumortumor immunology
Description preview
The overarching mission of the Cancer Immunology (CI) Research Program is to improve understanding of the immune response to cancer and to discover and test novel approaches to harness the immune response to improve patient outcomes. The Program was ranked outstanding to exceptional in the last renewal. Marcus Bosenberg, MD, PhD, Carla Rothlin,…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click